CF Industries (NYSE:CF) -6.8% in Friday's trading as J.P. Morgan downgrades shares to Underweight from Neutral with a $75 ...

J.P. Morgan downgraded PVH Corp (NYSE:PVH) to "Neutral" on a slower-than-expected recovery in topline growth amid global macroeconomic challenges and foreign exchange pressures.

What are biopharma VCs looking to invest in this year? Autoimmune disorders, osteoporosis, and cardiovascular disease are ...

This week on “The Top Line,” we break down the biggest stories out of JPM, from J&J’s blockbuster acquisition of ...

J.P. Morgan analyst Ranjan Sharma maintained a Buy rating on Grab (GRAB – Research Report) on January 21 and set a price target of $5.60. The ...

Jamie Dimon, chairman and CEO, noted in the release that in the asset and wealth management division client net inflows ...

Health care executives continue to reimagine and reshape their organizations. Their ideas were developing in real time during ...

J.P. Morgan analyst Mark Strouse maintained a Hold rating on Bloom Energy (BE – Research Report) yesterday and set a price target of $16.00.

The Westin St. Francis Hotel in Union Square will once again be host for one of the biggest conventions in the city--the J.P.

Cautious Optimism for Deal Making. The general consensus is that we will likely see an increase in M&A and capital market transactions in the ...

Dozens of Massachusetts biotech leaders will be heading to San Francisco this upcoming week for the 2025 J.P. Morgan ...

Investing.com -- J.P. Morgan analysts have upgraded their rating for Aviva plc (LON: AV) to "overweight" from "neutral," ...